Product
Listaftoclax
1 clinical trial
2 indications
Indication
Chronic Myeloid LeukemiaClinical trial
A Phase I Study of Decitabine, Lisaftoclax, and Olverembatinib in Patients With Advanced Chronic Myeloid Leukemia and Philadelphia Chromosome-Positive Acute Myeloid LeukemiaStatus: Not yet recruiting, Estimated PCD: 2027-01-01